$JAZZ has received 5 mentions from 2 distinct FinTwit voices over the past 12 months, with discussion beginning on 2025-07-09. Jacob Plieth (@jacobplieth) accounts for the majority of activity with 4 mentions, while Adam Feuerstein (@adamfeuerstein) contributed 1 mention. The biotech category has been the primary focus for $JAZZ discussion among these voices. Most recent mentions occurred in May 2026, with Plieth discussing Jazz Pharmaceuticals' historical decision regarding Immunogen ADC candidates, and earlier mentions in February and January 2026 contextualized the company's market position relative to other biotech firms.